Lexicon Pharmaceuticals (LXRX) Other Working Capital Changes (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Other Working Capital Changes of -$195000.0 for Q1 2026, up 83.92% year-over-year from -$106022.0 in Q1 2025, and up 79.79% on a QoQ basis from -$965000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) has 17 years of Other Working Capital Changes data on file, last reported at -$195000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 83.92% year-over-year to -$195000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$514000.0 (up 76.63% YoY) and the FY2025 annual result came in at -$1.5 million, down 32.99% from the prior year.
- Other Working Capital Changes climbed to -$195000.0 in Q1 2026 per LXRX's latest filing, from -$965000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.8 million in Q2 2023 and bottomed at -$3.1 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$191000.0 (2025), against an average of $19764.7.
- The widest annual swing landed in 2022, when Other Working Capital Changes slumped 3175.0%; it then surged 725.97% in 2023.
- Tracing LXRX's Other Working Capital Changes over 5 years: stood at -$154000.0 in 2022, then jumped by 725.97% to $964000.0 in 2023, then tumbled by 166.29% to -$639000.0 in 2024, then sank by 51.02% to -$965000.0 in 2025, then jumped by 79.79% to -$195000.0 in 2026.
- Per Business Quant, the three latest LXRX Other Working Capital Changes figures stand at -$195000.0 (Q1 2026), -$965000.0 (Q4 2025), and -$191000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -195,000.00 |
| Mar 31, 2026 | -195,000.00 |
| Dec 31, 2025 | -965,000.00 |
| Dec 31, 2025 | -965,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Jun 30, 2025 | 837,000.00 |
| Jun 30, 2025 | 837,000.00 |
| Mar 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -639,000.00 |
| Dec 31, 2024 | -639,000.00 |
| Sep 30, 2024 | -3.06 Mn |
| Sep 30, 2024 | -3.06 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | -166,000.00 |
| Mar 31, 2024 | -166,000.00 |
| Dec 31, 2023 | 964,000.00 |
| Dec 31, 2023 | 964,000.00 |
| Sep 30, 2023 | -1.71 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 867,000.00 |
| Mar 31, 2023 | 867,000.00 |
| Dec 31, 2022 | -154,000.00 |
| Dec 31, 2022 | -154,000.00 |
| Sep 30, 2022 | -262,000.00 |
| Sep 30, 2022 | -262,000.00 |
| Jun 30, 2022 | 939,000.00 |
| Jun 30, 2022 | 939,000.00 |
| Mar 31, 2022 | -207,000.00 |
| Mar 31, 2022 | -207,000.00 |
| Dec 31, 2021 | -2.43 Mn |
| Dec 31, 2021 | -2.43 Mn |
| Sep 30, 2021 | -8,000.00 |
| Sep 30, 2021 | -8,000.00 |
| Jun 30, 2021 | 644,000.00 |
| Jun 30, 2021 | 644,000.00 |
| Mar 31, 2021 | -1.10 Mn |
| Mar 31, 2021 | -1.10 Mn |
| Dec 31, 2020 | -6.43 Mn |
| Dec 31, 2020 | -6.43 Mn |
| Sep 30, 2020 | 1.87 Mn |
| Sep 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 4.24 Mn |
| Jun 30, 2020 | 4.24 Mn |
| Mar 31, 2020 | -102,000.00 |
| Mar 31, 2020 | -102,000.00 |
| Dec 31, 2019 | 25.50 Mn |
| Dec 31, 2019 | 25.50 Mn |
| Sep 30, 2019 | -25.74 Mn |
| Sep 30, 2019 | -25.74 Mn |
| Jun 30, 2019 | -2.20 Mn |
| Jun 30, 2019 | -2.20 Mn |
| Mar 31, 2019 | 2.02 Mn |
| Mar 31, 2019 | 2.02 Mn |
| Dec 31, 2018 | 895,000.00 |
| Dec 31, 2018 | 895,000.00 |
| Sep 30, 2018 | 24.17 Mn |
| Sep 30, 2018 | 24.17 Mn |
| Jun 30, 2018 | -25.21 Mn |
| Jun 30, 2018 | -25.21 Mn |
| Mar 31, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Sep 30, 2017 | 20.77 Mn |
| Sep 30, 2017 | 20.77 Mn |
| Jun 30, 2017 | -20.76 Mn |
| Jun 30, 2017 | -20.76 Mn |
| Mar 31, 2017 | -33,000.00 |
| Mar 31, 2017 | -33,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Dec 31, 2016 | 7,000.00 |
| Sep 30, 2016 | 25,000.00 |
| Sep 30, 2016 | 25,000.00 |
| Jun 30, 2016 | -12.19 Mn |
| Jun 30, 2016 | -12.19 Mn |
| Mar 31, 2016 | 12.19 Mn |
| Mar 31, 2016 | 12.19 Mn |
| Dec 31, 2015 | -172.20 Mn |
| Dec 31, 2015 | -172.20 Mn |
| Sep 30, 2015 | 1.26 Mn |
| Sep 30, 2015 | 1.26 Mn |
| Jun 30, 2015 | -1.98 Mn |
| Jun 30, 2015 | -1.98 Mn |
| Mar 31, 2015 | 1.57 Mn |
| Mar 31, 2015 | 1.57 Mn |
| Dec 31, 2014 | 1.17 Mn |
| Dec 31, 2014 | 1.17 Mn |
| Sep 30, 2014 | 1.41 Mn |
| Sep 30, 2014 | 1.41 Mn |
| Jun 30, 2014 | -2.72 Mn |
| Jun 30, 2014 | -2.72 Mn |
| Mar 31, 2014 | 18,000.00 |
| Mar 31, 2014 | 18,000.00 |
| Dec 31, 2013 | -71,000.00 |
| Dec 31, 2013 | -71,000.00 |
| Sep 30, 2013 | 397,000.00 |
| Sep 30, 2013 | 397,000.00 |
| Jun 30, 2013 | 1.75 Mn |
| Jun 30, 2013 | 1.75 Mn |
| Mar 31, 2013 | -2.09 Mn |
| Mar 31, 2013 | -2.09 Mn |
| Dec 31, 2012 | 5.35 Mn |
| Dec 31, 2012 | 5.35 Mn |
| Sep 30, 2012 | -2.42 Mn |
| Sep 30, 2012 | -2.42 Mn |
| Jun 30, 2012 | -1.44 Mn |
| Jun 30, 2012 | -1.44 Mn |
| Mar 31, 2012 | -1.40 Mn |
| Mar 31, 2012 | -1.40 Mn |
| Dec 31, 2011 | -1.20 Mn |
| Dec 31, 2011 | -1.20 Mn |
| Sep 30, 2011 | 1.33 Mn |
| Sep 30, 2011 | 1.33 Mn |
| Jun 30, 2011 | -1.31 Mn |
| Jun 30, 2011 | -1.31 Mn |
| Mar 31, 2011 | 315,000.00 |
| Mar 31, 2011 | 315,000.00 |
| Dec 31, 2010 | -6.55 Mn |
| Dec 31, 2010 | -6.55 Mn |
| Sep 30, 2010 | 5.90 Mn |
| Sep 30, 2010 | 5.90 Mn |